- The FDA approved a new treatment for MS patients: Ocrevus (ocrelizumab) Intravenous infusion / injected. It
halts the progression of the disease with relatively few side affects.
The FDA cleared the drug for treating a severe form of MS. They also
cleared the drug to treat people with a more common form of the
disease. (ABC News, March 29, 2017)